Introduction
============

Diarylheptanoids have been isolated from various genera such as *Acer* (Aceraceae), *Platycarya*(Juglandaceae), *Myrica*(Myricaceae), *Centrolobium* (Leguminosae), *Alpinia*, *Curcuma*, and *Zingiber* (Zingiberaceae), and *Alnus* and *Betula*(Betulaceae) ([@B1], [@B2]). The structure of diarylheptanoids consists of two benzene rings linked by a linear C~7~-aliphatic chain with varying functional groups on the aryl and aliphatic moieties. They can be sub-grouped into open chain linear or cyclic compounds ([@B2], [@B3]). The latter group includes *meta*-*meta* bridged biphenyls and *meta*-*para* diphenyl ethers ([@B2], [@B3]). In addition, more complex diarylheptanoids with the basic skeleton extended by fragments such as arylbutyl, chalcone or flavonoid moieties have been isolated ([@B4]). They showed wide variety of biological activities as antioxidant, anti-inflammatory, antitumor, neuro-protective, estrogenic, hepatoprotective, anti-influenza, anti-trypanosomal, antiviral, and leishmanicidal ([@B3], [@B5]-[@B15]). In Japan, *Alnus japonica* (Betulaceae) is widely distributed in the low mountains ([@B12], [@B13]). Previous phytochemical study of *A*.*japonica*revealed the presence of diarylheptanoids, triterpenoids, flavonoids, and hydrolysable tannins ([@B12]-[@B22]). Continuing our study on *A*.*japonica*stem bark resulted in the isolation and characterization of alnuheptanoid B, a new cyclic diarylheptanoid, along with four known cyclic diarylheptanoids ([Figure 1](#F1){ref-type="fig"}, [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). They were assessed for their free radical scavenging activity using DPPH assay. Also, their anti-inflammatory effect was estimated using carrageenin induced paw edema method.

Experimental
============

*General*

Melting points were determined by Electrothermal Digital Melting Point 9100 instrument (England). Shimadzu 1601 UV/VIS and Shimadzu Infrared-400 (Japan) spectrophotometers were used to measure the UV and IR spectra, respectively. Optical rotation was measured by Perkin-Elmer Polarimeter 341 LC Model (USA). LRMS spectra were assessed by a MATTSQ7000 Finnigan spectrometer. A Micromass Qtof 2 spectrometer was used for HRESIMS spectra measurements. Bruker Avance DRX 400 (Bruker, USA) was used to record NMR spectra. HPLC separations were performed on a HPLC system consisting of a UV L-7400 detector (280 nm) and a Lachrom-Merck L-7100 Hitachi pump using a C~18~ column (250 × 8 mm i.d., Eurospher 100, Germany). A linear gradient (H~2~O:MeOH 80:20 % to MeOH 100 % over 45 min) was applied. Chromatographic separation was achieved using RP~18~ (0.04-0.063 mm) and silica gel (0.04-0.063 mm) 60 (Merck, Germany). The TLC analysis was performed using the following systems: MeOH:CHCl~3~ (10:90, S~1~), MeOH:CHCl~3~ (15:85, S~2~), and *n*-BuOH:H~2~O:HOAc (4:5:1, S~3~). Pre-coated silica gel 60 F~254~ TLC plates (0.2 mm, Merck) was used for TLC. Propyl gallate (PG), 2,2-diphenyl-1-picrylhydrazyl (DPPH), carrageenin, and indomethacin were provided by Sigma-Aldrich Co. (Taufkirchen, Germany).

*Plant material*

The plant sample was obtained from the Heinrich-Heine University\`s botanical garden (Düsseldorf, Germany) in March 2005. The plant was taxonomically authenticated and identified by Peter Westhoff, Prof. of Plants Molecular Biology and Development (Heinrich-Heine University, Germany). A specimen (Registration code AJB-2005) was kept at the Faculty of Pharmacy, Department of Pharmacognosy, Al-Azhar University, Egypt.

*Extraction and isolation*

The powdered stem bark (200 g) was extracted exhaustively with EtOH (70 %, 4 × 2 L). The EtOH extract was concentrated to afford 12 g brown residue. The residue was chromatographed over vacuum liquid chromatography (VLC) using 50 % CHCl~3~:*n*-hexane (500 mL x 4) and EtOAc (500 mL x 4) to obtain 2.6 and 4.1 g, respectively. The VLC of the EtOAc (4.1 g) fraction using CHCl~3~:MeOH gradient elution afforded 6 sub-fractions (A-F). Sub-fractions B-E were previously investigated by authors ([@B13]). SiO~2~ column (2 cm 50 cm 50 g) of sub-fraction A (470 mg, CHCl~3~:MeOH 90:10 v/v) with CHCl~3~:MeOH gradient, followed by semi-preparative HPLC yielded 1 (22.1 mg, white needles) and 2 (14.8 mg, white needles). RP-18 column (2 cm 50 cm 60 g) of sub-fraction F (392 mg, CHCl~3~:MeOH 40:60 v/v) using MeOH:H~2~O gradient elution followed by HPLC gave 3 (13.7 mg), 4 (15.3 mg), and 5 (18.9 mg).

*Myricanone* *(1)*

White needles (22.1 mg); m.p. 191-192 °C; UV (MeOH) ~max~: 215, 258, 295 nm; NMRdata: see [Table 1](#T1){ref-type="table"}; ESIMS: *m*/*z* 357 \[M + H\]^+^.

*S-* *Myricanol* *(2)*

White needles (14.8 mg); m.p. 103-104 °C; \[α\]~D~ +38.5 (*c*0. 5, CHCl~3~); UV (MeOH) ~max~: 221, 259, 295 nm; NMR data: see [Table 1](#T1){ref-type="table"}; ESIMS: *m*/*z* 359 \[M + H\]^+^.

*Alnuheptanoids* *B (3)*

White amorphous powder (13.7 mg); UV (MeOH) ~max~ (log  ): 219 (4.71), 251 (4.36), 293 (3.95) nm; IR (KBr)  ~max~: 3465, 1725, 1715, 1598 cm^-1^; NMR data: see [Table 2](#T2){ref-type="table"}; ESIMS: *m*/*z* 561 \[M + H\]^+^, 398.9 \[(M + H)-Glu\]^+^, 357.2 \[(M + H)-(Glu+Acetyl)\]^+^; HRESIMS: *m*/*z* 561.2339 (calc for C~29~H~37~O~11~, 561.2336 \[M + H\]^+^).

*Myricanone* *5-O\--D-glucopyranoside (4)*

White amorphous powder (15.3 mg); UV (MeOH) ~max~: 220, 251, 294 nm; NMR data: see [Table 2](#T2){ref-type="table"}; ESIMS: *m*/*z* 519 \[M + H\]^+^, 357 \[(M + H)-Glu\]^+^.

*(+)-S-* *Myricanol* *5-O\--D-glucopyranoside (5)*

White amorphous powder (18.9 mg); \[α\]~D~ +82.3 (*c*0. 5, CH~3~OH); UV (MeOH) ~max~: 231, 253, 294 nm; NMR data: see [Table 2](#T2){ref-type="table"}; ESIMS: *m*/*z* 521 \[M + H\]^+^, 359 \[(M + H)-Glu\]^+^.

*Antioxidant activity*

The antioxidant effect of compounds 1-5 was evaluated by 2,2\`-diphenylpicrylhydrazyl (DPPH) assay as previously outlined ([@B23], [@B24]).

*Carrageenin-induced rat paw edema method*

The anti-inflammatory activity was evaluated on adult male albino rats (120-150 g b. wt.) using the same procedures as previously described ([@B23], [@B25] ,[@B26]).

*Statistical analysis*

All data were expressed as mean ± standard error of mean using the student *t* test. ANOVA (one-way analysis of variance) was used for evaluation of statistical significance. The values were considered to be significantly different when *P* \< 0.01.

Results and Discussion
======================

Compound 3 was isolated as white amorphous powder. A molecular formula C~29~H~36~O~11~was established from the HRESIMS quasi-molecular ion peak at *m*/*z* 561.2339 \[M + H\]^+^. The IR, UV, and NMR spectral data of 3 were in agreement with those of 4 except for the appearance of new signals at ~H~ 2.08 /~C~ 20.8 (CO[CH]{.ul}~3~) and 171.7 ([CO]{.ul}CH~3~) characteristic for an acetyl group in 3. Its attachment at C-17 was confirmed by the ^3^*J* HMBC cross peak of H-16 to the carbonyl group of acetyl moiety at ~C~ 171.7 and further secured by the ESIMS ion peak at 357.2 \[(M + H)-(Glu+Acetyl)\]^+^. In addition, 3 was 42 mass units and one degree of unsaturation more than 4, confirming the presence of the acetyl moiety. The UV absorption maxima at 219, 251, and 293 nm indicated a diarylheptanoid structure of 3 ([@B27]). Its IR spectrum displayed bands ascribable to hydroxyl (3465 cm^-1^), ester carbonyl (1725 cm^-1^), ketone carbonyl (1715 cm^-1^), and benzene (1598 cm^-1^) functionalities ([@B28]). The ^1^H NMR spectrum showed two singlet methoxy groups at ~H~ 3.95 (4-OCH~3~) and 3.79 (3-OCH~3~) ([Table 2](#T2){ref-type="table"}). They correlated with the carbons resonating at ~C~61.9 (4-OCH~3~) and 61.7 (3-OCH~3~), respectively in HMQC spectrum. Their connectivity at C-4 and C-3 was proven by the HMBC cross peaks of 4-OCH~3~ to C-4 (~C~ 145.0) and 3-OCH~3~ to C-3 (~C~ 146.9). Four aromatic proton signals at ~H~ 7.06 (dd, *J* = 6.6, 1.5 Hz, H-15), 6.87 (d, *J* = 6.6 Hz, H-16), 6.69 (d, *J* = 1.5 Hz, H-18), and 6.67 (s, H-19), which correlated with carbons at ~C~ 129.6 (C-15), 122.8 (C-16), 132.4 (C-18), and 129.1 (C-19) in HMQC spectrum, indicating the presence of 1,2,4-*tri*-substituted and 1,2,3,4,5-*penta*-substituted benzene moieties in 3 (20,21). They were established by the COSY cross peaks of H-15 to H-16 and H-18 and further secured by the HMBC correlations of H-15 to C-17 and C-18, H-16 to C-1 and C-14, H-18 to C-14 and C-17, and H-19 to C-3 and C-5 ([Figure 2](#F2){ref-type="fig"}). The connectivity of two phenyl moieties at C~1~-C~2~ was secured based on the HMBC cross peaks of H-19 to C-1 and H-18 to C-2 ([Figure 2](#F2){ref-type="fig"}). Moreover, the doublet proton signal at ~H~ 4.80 (*J* = 7.6 Hz, H-1\`) showed cross peak to the signal at ~C~ 105.0 (C-1\`), indicating the presence of *β*-glucopyranose moiety ([@B23], [@B26]). This was established by the observed ESIMS fragment peaks at *m*/*z* 398.9 \[(M + H)-Glu\]^+^ and 357.2 \[(M + H)-(Glu+Acetyl)\]^+^. In the HMBC, the cross peak of H-1\` to C-5 (~C~ 148.7) established the placement of glucose at C-5. Furthermore, signals for six methylene groups at ~H~ 1.80-3.07 and ketone carbonyl at ~C~ 213.6 (C-11), characteristic for heptanoid moiety in 3 were observed. In the COSY spectrum, the spin system started from H-7 to H-10 and cross peak of H-12 to H-13 established this moiety. It was secured by the observed HMBC cross peaks of H-9/C-7 and C-11, H-10/C-8, H-12/C-13, and H-13/C-11. The attachment of heptanoid moiety at C6-C14 of the biphenyl moiety was secured by the HMBC cross peaks of H-8/C-6, H-19/C-7, and H-18/C-13. Consequently, 3 was concluded to be 17-*O*-acetyl myricanone 5-*O*-*β*-glucopyranoside and named alnuheptanoid B.

Compounds 1-5 were identified to be myricanone (1) ([@B29], [@B30]), (+)-*S*-myricanol ([@B2]) ([@B30],[@B31]), myricanone 5-*O*- -D-glucopyranoside ([@B4]) ([@B32]), and (+)-*S*-myricanol 5-*O*- -D-glucopyranoside ([@B5]) ([@B27]) by the interpretation of the spectroscopic data and comparison with literature.

###### 

^1^H and ^13^C NMR data of compounds 1 and 2 (400 and 100 MHz, CDCl~3~).

  ------------------------------------------------------------------------------
  **No.**    **1**                **2**                             
  ---------- -------------------- ------------ -------------------- ------------
  1          \-                   125.4 C      \-                   124.7 C

  2          \-                   123.1 C      \-                   122.6 C

  3          \-                   145.9 C      \-                   145.8 C

  4          \-                   138.7 C      \-                   138.6 C

  5          \-                   147.8 C      \-                   147.7 C

  6          \-                   123.0 C      \-                   123.4 C

  7          2.72 m               26.8 CH~2~   2.55 m\              25.7 CH~2~
                                               1.93 m               

  8          1.94 m               24.4 CH~2~   2.78 m\              25.4 CH~2~
                                               1.92 m               

  9          1.87 m               21.8 CH~2~   1.69 m\              23.0 CH~2~
                                               1.55 m               

  10         2.77 m               46.1 CH~2~   1.90 m\              39.4 CH~2~
                                               1.54 m               

  11         \-                   213.6 C      4.08 m               68.6 CH

  12         2.81 m               42.5 CH~2~   2.33 m\              34.7 CH~2~
                                               1.72 m               

  13         3.03 m               28.8 CH~2~   2.94 m               26.9 CH~2~

  14         \-                   132.4 C      \-                   130.6 C

  15         7.05 dd (6.6, 2.0)   128.9 CH     7.08 dd (7.0, 1.5)   129.9 CH

  16         6.88 d (6.6)         116.9 CH     6.91 d (7.0)         116.8 CH

  17         \-                   151.7 C      \-                   151.4 C

  18         6.74 d (2.0)         132.4 CH     7.17 d (1.5)         133.1 CH

  19         6.60 s               128.9 CH     6.90 s               129.4 CH

  3-OCH~3~   3.81 s               61.3 CH~3~   3.87 s               61.3 CH~3~

  4-OCH~3~   3.98 s               61.4 CH~3~   3.99 s               61.4 CH~3~

  17-OH      7.66 brs             \-           7.70 brs             \-

  OH         5.91 brs             \-           5.90 brs             \-
  ------------------------------------------------------------------------------

###### 

^1^H and ^13^C NMR data of compounds 3-5 (400 and 100 MHz, DMSO-*d*~6~).

  -------------------------------------------------------------------------------------------------------------------
  **No.**      **3**                **4**         **5**                                                  
  ------------ -------------------- ------------- -------------------- ------------ -------------------- ------------
  1            \-                   130.9 C       \-                   128.9 C      \-                   128.4 C

  2            \-                   128.9 C       \-                   128.0 C      \-                   128.0 C

  3            \-                   146.9 C       \-                   148.5 C      \-                   148.3 C

  4            \-                   145.0 C       \-                   145.3 C      \-                   145.1 C

  5            \-                   148.7 C       \-                   148.7 C      \-                   148.8 C

  6            \-                   124.8 C       \-                   126.1 C      \-                   126.0 C

  7            2.82 m\              27.8 CH~2~    2.81 m               27.1 CH~2~   2.54 m               25.8 CH~2~
               2.72 m                                                                                    

  8            1.90 m\              24.7 CH~2~    1.75 m               24.2 CH~2~   2.71 m               26.0 CH~2~
               1.86 m                                                                                    

  9            1.80 m               21.9 CH~2~    1.51 m               21.2 CH~2~   1.28 m\              22.5 CH~2~
                                                                                    1.21 m               

  10           2.75 m\              45.8 CH~2~    2.63 m               45.1 CH~2~   1.63 m\              39.3 CH~2~
               2.67 m                                                               1.35 m               

  11           \-                   213.6 C       \-                   213.2 C      3.95 m               66.5 CH

  12           2.77 m               42.4 CH~2~    2.74 m               41.7 CH~2~   2.09 m\              34.4 CH~2~
                                                                                    1.49 m               

  13           3.07 m\              28.6 CH~2~    2.84 m               28.0 CH~2~   2.83 m\              26.8 CH~2~
               2.95 m                                                               2.78 m               

  14           \-                   132.1 C       \-                   130.7 C      \-                   129.4 C

  15           7.06 dd (6.6, 1.5)   129.6 CH      6.95 dd (6.6, 1.7)   128.3 CH     6.96 dd (6.6, 1.5)   129.1 CH

  16           6.87 d (6.6)         122.7 CH      6.71 d (6.6)         115.5 CH     6.74 d (6.6)         115.6 CH

  17           \-                   149.8 C       \-                   152.3 C      \-                   152.0 C

  18           6.69 d (1.5)         132.4 CH      6.45 d (1.7)         133.2 CH     6.92 brs             134.6 CH

  19           6.67 s               129.1 CH      6.35 s               128.5 CH     6.60 s               129.5 CH

  1\`          4.80 d (7.6)         105.0 CH      4.79 d (7.6)         103.4 CH     4.84 d (7.6)         103.9 CH

  2\`          3.33 m               74.1 CH       3.19 m               74.0 CH      3.04 m               74.0 CH

  3\`          3.37 m               77.2 CH       3.06 m               77.0 CH      3.06 m               77.1 CH

  4\`          3.95 m               69.9 CH       3.16 m               69.9 CH      3.17 m               69.9 CH

  5\`          3.67 m               76.3 CH       3.24 m               76.4 CH      3.23 m               76.5 CH

  6\`          3.86 m\              62.0 CH~2~    3.61 m\              61.0 CH~2~   3.58 m\              60.9 CH~2~
               3.70 m                             3.43 m                            3.42 m               

  3-OCH~3~     3.79 s               61.7 CH~3~    3.75 s               60.1 CH~3~   3.81 s               60.1 CH~3~

  4-OCH~3~     3.95 s               61.9 CH~3~    3.81 s               60.9 CH~3~   3.83 s               60.8 CH~3~

  17-OH        \-                   \-            8.91 brs             \-           \-                   \-

  2\`-OH       \-                   \-            5.03 brs             \-           5.03 d (2.5)         \-

  3\`-OH       \-                   \-            4.93 d (4.3)         \-           4.93 d (4.1)         \-

  4\`-OH       \-                   \-            4.09 d (4.3)         \-           4.41 d (3.8)         \-

  5\`-OH       \-                   \-            5.28 d (3.5)         \-           5.22 d (3.5)         \-

  6\`-OH       \-                   \-            4.34 t (4.6)         \-           3.36 t (4.6)         \-

  17-COCH~3~   2.08 s               20.8 CH~3~\   \-                   \-           \-                   \-
                                    171.7 C                                                              
  -------------------------------------------------------------------------------------------------------------------

The antioxidant activity of the isolated cyclic diarylheptanoids ([@B1]-[@B5]) was determined using DPPH free radical scavenging system at concentration 50 *µ*M. The results showed that, 1 and 2 had significant antioxidant activity. While, 3-5 showed moderate activity in comparison with propyl gallate (a known antioxidant) ([Table 3](#T3){ref-type="table"}). Their antioxidant effect was related to the number of free hydroxyl groups in their structures. Compounds 1 and 2 showed significant activities compared to propyl gallate at the same concentration. However, blocking of the hydroxyl group by an acetyl or glucose moiety leads to a decrease in the activity as in 3-5 ([@B33]).

###### 

The DPPH radical scavenging activity results.

  **Sample**       **DPPH (% Inhibition)**
  ---------------- -------------------------
  1                63.10 ± 0.81
  2                70.14 ± 0.55
  3                41.16 ± 0.64
  4                49.09 ± 0.76
  5                52.11 ± 0.59
  Propyl gallate   97.31 ± 0.37

Conc. 50 µM; Each value represents the mean ± S.D.; *n* = 3.

Compounds 1-5 were evaluated for their anti-inflammatory effects using carrageenin induced paw edema model. Compound 2 showed the highest activity comparable to indomethacin (10 mg/kg) ([Table 4](#T4){ref-type="table"}). Also, 1, 3, 4, and 5 showed potent activity at dose 10 mg/kg after 4 h. The phenolic compounds are known to inhibit prostaglandins synthesis enzymes, more specifically the endoperoxide ([@B26]). It was reported that, prostaglandin like substances are released during the second phase of carrageenin induced edema ([@B34], [@B35]). So, the anti-inflammatory effects of the tested compounds may be due to inhibition of prostaglandin like substances.

###### 

The anti-inflammatory activity results.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Groups\              Dose mg/kg   0 hr        1 hr   2 hr                                        4 hr    6 hr                                                                                                                                                
  n = 6                                                                                                                                                                                                                                                        
  -------------------- ------------ ----------- ------ ------------------------------------------- ------- ------------------------------------------- ------- ------------------------------------------- ------- ------------------------------------------- -------
  Inflamed                          3.95±0.09   0.00   5.76±0.12                                   0.00    6.51±0.11                                   0.00    6.97±0.10                                   0.00    4.88±0.13                                   0.00

  Inflamed + Indom.c   10           3.94±0.14   0.25   5.39±0.14[\*](#TFN1){ref-type="table-fn"}   6.42    3.41±0.15[\*](#TFN1){ref-type="table-fn"}   47.62   3.12±0.08[\*](#TFN1){ref-type="table-fn"}   55.24   2.99±0.07[\*](#TFN1){ref-type="table-fn"}   38.73

  Inflamed + **1**     10           3.89±0.12   1.52   3.97±0.11[\*](#TFN1){ref-type="table-fn"}   29.98   3.77±0.12[\*](#TFN1){ref-type="table-fn"}   42.09   3.51±0.07[\*](#TFN1){ref-type="table-fn"}   49.64   3.24±0.11[\*](#TFN1){ref-type="table-fn"}   33.61

  Inflamed + **2**     10           3.87±0.07   2.03   3.94±0.10[\*](#TFN1){ref-type="table-fn"}   31.60   3.62±0.06[\*](#TFN1){ref-type="table-fn"}   44.39   3.38±0.13[\*](#TFN1){ref-type="table-fn"}   51.51   3.08±0.12[\*](#TFN1){ref-type="table-fn"}   36.89

  Inflamed + **3**     10           3.93±0.12   0.51   4.37±0.10[\*](#TFN1){ref-type="table-fn"}   24.13   3.99±0.13[\*](#TFN1){ref-type="table-fn"}   38.71   3.74±0.11[\*](#TFN1){ref-type="table-fn"}   46.34   3.49±0.13[\*](#TFN1){ref-type="table-fn"}   28.48

  Inflamed + **4**     10           3.94±0.14   0.25   4.32±0.15[\*](#TFN1){ref-type="table-fn"}   25.00   3.91±0.11[\*](#TFN1){ref-type="table-fn"}   39.94   3.70±0.09[\*](#TFN1){ref-type="table-fn"}   46.92   3.42±0.15[\*](#TFN1){ref-type="table-fn"}   29.92

  Inflamed + **5**     10           3.91±0.08   1.01   4.07±0.14[\*](#TFN1){ref-type="table-fn"}   29.34   3.87±0.09[\*](#TFN1){ref-type="table-fn"}   40.55   3.69±0.11[\*](#TFN1){ref-type="table-fn"}   47.06   3.31±0.08[\*](#TFN1){ref-type="table-fn"}   32.17
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Each value represents the mean ± S.E.M., *n* = 6;

Significant different from inflamed control group at *P* \< 0.01;

PET: Paw edema thickness;

\% IN: % Inhibition;

Indom: Indomethacin.

The observed activity of these compounds might be through the inhibition of the inflammatory prostanoids ([@B36], [@B37]). In this work, we can make a conclusion on the SAR of the tested cyclic diarylheptanoids. It was observed that, the phenolic hydroxyl groups are responsible for anti-inflammatory activity as in 1 and 2 ([@B36], [@B37]). Glucosidation of phenolic OH group leads to reduce the activity as in 3-5. Secondary alcoholic hydroxyl group in aliphatic chain might increase the activity as in 1 and 5 in comparison to the other compounds.

![Structures of compounds **1**-**5**.](ijpr-16-083-g001){#F1}

![Important ^1^H-^1^H COSY and HMBC correlations of alnuheptanoid B (**3**).](ijpr-16-083-g002){#F2}

Conclusions
===========

A new cyclic diarylheptanoid and four known compounds were isolated from *A*.*japonica* for the first time. Their chemical structures were established by different spectroscopic analyses. Compounds 1 and 2 showed significant antioxidant activity. Compound 2 exhibited potent anti-inflammatory activity.
